University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States.
Schizophr Res. 2010 May;118(1-3):232-9. doi: 10.1016/j.schres.2010.01.007. Epub 2010 Feb 6.
We previously reported reduced prefrontal cortex (PFC) grey matter volume among first episode, antipsychotic-naïve schizophrenia subjects (SZ) exposed to HSV1 but not among healthy subjects (HS) (Prasad et al., 2007). Independently, rs1051788, an exonic polymorphism of the MHC Class I polypeptide-related sequence B (MICB) gene was associated with HSV1 seropositivity, as well as SZ risk. In this study, we examined whether PFC grey matter changes associated with HSV1 exposure varied against the background of MICB genotypes.
We examined Caucasian individuals from the sample we studied in our previous report (Prasad et al., 2007) (SZ, n=21 and HS, n=19). Whole brain voxelwise analysis of structural MRI scans was conducted using Statistical Parametric Mapping, ver 5 (SPM5). The impact of rs1051788 variation and HSV1 seropositivity on grey matter volumes was examined using regression models on the combined sample of cases and controls, and then within each diagnostic group.
In the combined sample of cases and controls, we observed the main effects of HSV1 seropositivity and genotypes, and a significant joint effect of HSV1 seropositivity and genotype mainly in the PFC. The joint effect was more prominent among cases than among controls.
Our observations suggest that rs1051788 and HSV1 seropositivity are associated individually and jointly with reduced PFC grey matter volume. The patterns of these associations differ by diagnostic status, and these factors explain only a "small" portion of the variance in the grey matter volume reductions.
我们之前的报告显示,与健康对照者(HS)相比,单纯疱疹病毒 1(HSV1)暴露的首发、抗精神病药物初治精神分裂症(SZ)患者的前额叶皮质(PFC)灰质体积减少(Prasad 等人,2007 年)。此外,MHC Ⅰ类多肽相关序列 B(MICB)基因的外显子多态性 rs1051788 与 HSV1 血清阳性以及 SZ 风险相关。在这项研究中,我们检查了 PFC 灰质变化与 HSV1 暴露的相关性是否存在 MICB 基因型的背景差异。
我们检查了我们之前报告(Prasad 等人,2007 年)中研究样本的白种人个体(SZ,n=21;HS,n=19)。使用统计参数映射,版本 5(SPM5)对结构磁共振成像扫描的全脑体素进行分析。使用病例和对照组的组合样本中的回归模型,以及在每个诊断组内,检查 rs1051788 变异和 HSV1 血清阳性对灰质体积的影响。
在病例和对照组的组合样本中,我们观察到 HSV1 血清阳性和基因型的主要影响,以及 HSV1 血清阳性和基因型的显著联合作用,主要在 PFC 中。联合作用在病例中比在对照组中更为明显。
我们的观察结果表明,rs1051788 和 HSV1 血清阳性单独和联合与 PFC 灰质体积减少有关。这些关联的模式因诊断状态而异,这些因素仅能解释灰质体积减少的“一小部分”方差。